| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |